Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study.

ABSTRACT:

Introduction

There have been significant advancements in risk identification and treatment for ovarian cancer over the last decade. However, their impact on health services costs is unclear. This study estimated the direct health system costs (government perspective) for women diagnosed with ovarian cancer in Australia during 2006-2013, as a benchmark prior to opportunities for precision-medicine approaches to treatment, and for health care planning.

Methods

Using cancer registry data, we identified 176 incident ovarian cancers (including fallopian tube and primary peritoneal cancer) in the Australian 45 and Up Study cohort. Each case was matched with four cancer-free controls on sex, age, geography, and smoking history. Costs were derived from linked health records on hospi

SUBMITTER: Goldsbury DE 

PROVIDER: S-EPMC10112806 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature